Re: [AMBER] Vlimit exceeded, box deformation, ligand receptor distance change.

From: Dickson, Callum via AMBER <amber.ambermd.org>
Date: Thu, 21 May 2026 13:11:19 +0000

Hi,

Regarding the “vlimit exceeded” error, this normally indicates close contacts / high energy starting coordinates. An easy way to check for this is using the cpptraj “checkoverlap” command.

Regarding the specific question of deformation of the simulation box, with long MD timescales it has been seen that membrane simulations boxes can contract in either the X- or Y- dimension using the isotropic barostat, resulting in a thinning along one dimension. I would recommend the semi-isotropic barostat (which couples the X- and Y- dimensions), like this:

ntp=3, csurften=3, gamma_ten=0.0, ninterface=2,

Best regards,
Callum


From: Arti 2410204 via AMBER <amber.ambermd.org>
Date: Thursday, May 21, 2026 at 06:15
To: amber.ambermd.org <amber.ambermd.org>
Subject: [AMBER] Vlimit exceeded, box deformation, ligand receptor distance change.

EXTERNAL EMAIL– Use caution with any links or file attachments.

WARNING: This email failed our security checks and may not be from the actual sender. Use extreme caution with links, attachments, and replying to this email. If you suspect malicious behavior, report it via: https://go.merck.com/reportcyber

Dear AMBER users,

I would like to ask for suggestions regarding a possible connection between
some earlier observations in my *membrane protein–peptide simulations *and
the equilibration instability issues that I am currently encountering.

In earlier equilibration attempts, I completely removed the peptide
restraints and continued the simulation protocol. During those runs, I
observed that the distance between the peptide ligand and receptor
gradually increased over time despite being positional restrained on the
ligand and protein.
Additionally, while visualizing the trajectory in VMD, I noticed
significant deformation of the simulation box. The box appeared to become
increasingly elongated in one dimension while shrinking in another
dimension during the trajectory.

Initially, I suspected these effects might be related to artifacts or
normal membrane fluctuations. However, when I continued the equilibration
further, the simulations eventually failed with errors such as:




*"vlimit exceededCoordinate resetting cannot be accomplished.deviation is
too large."*

This makes me wonder whether the earlier ligand–receptor separation and box
deformation behavior were actually early indicators of system stability
issues.

I would greatly appreciate any suggestions regarding:

   - whether such box deformation behavior is expected during membrane
   equilibration,
   - Whether this may indicate instability in membrane equilibration,
   - and how to systematically troubleshoot this type of issue in AMBER
   membrane simulations.


Thank you very much for your time and help.
_______________________________________________
AMBER mailing list
AMBER.ambermd.org
http://lists.ambermd.org/mailman/listinfo/amber
This e-mail message, together with any attachments, contains information of Merck & Co., Inc.,Rahway, NJ, USA, and/or its affiliates, known as MSD outside of the United States and Canada, that may be confidential, proprietary, copyrighted and/or legally privileged. (Direct contact information for affiliates is available at - Contact us - MSD<https://www.msd.com/contact-us/>.) It is intended solely for the use of the individual or entity named on this message. If you are not the intended recipient, and have received this message in error, please notify us immediately by reply e-mail and then delete it from your system.
_______________________________________________
AMBER mailing list
AMBER.ambermd.org
http://lists.ambermd.org/mailman/listinfo/amber
Received on Thu May 21 2026 - 06:30:06 PDT
Custom Search